Trial Profile
Effect of Evacetrapib on the Pharmacokinetics of Digoxin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2018
Price :
$35
*
At a glance
- Drugs Evacetrapib (Primary) ; Digoxin
- Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2013 New trial record